The current valuation score of OmniAb Inc is 7.37, ranking 223 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -4.30, which is -50.77% below the recent high of -2.12 and -497.79% above the recent low of -25.72.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.